510(k) K113610

Device
ANA-SCREEN WITH MDSS
Applicant
Bio-Rad Laboratories
510(k) number
K113610
Product code
LKJ  
Decision
Substantially Equivalent (SESE)
Decision date
2012-07-09
Date received
2011-12-06
Regulation
866.5100
Classification name
Antinuclear Antibody, Antigen, Control
Medical specialty
Immunology
Review panel
Immunology
Device class
2
Clearance type
Special
Statement or summary
Summary
Third party reviewed
No

Applicant Contact#

Contact
Juang Wang
Address
Bioplex 2200 Division 5500 E. Second St. Benicia CA US 94510 94510

FDA Registration Numbers#

Source Documents#

510(k) summary PDF

Other 510(k) Records For Product Code LKJ  #

510(k), Device, Applicant table
510(k)DeviceApplicantDecision date
K210902EliA Ro52, EliA Ro60Phadia AB2022-07-27
K082759ELIA CENP IMMUNOASSAY, ELIA U1RNP IMMUNOASSAY, ELIA SM IMMUNOASSAY, ELIA RO IMMUNOASSAYPhadia US, Inc.2009-04-10
K081104AESKULISA ANA HEP-2, REF 30-7115USAesku Diagnostics2008-05-02
K041658BIOPLEX 200 ANA SCREEN ON THE BIOPLEX 2200 MULTI-ANALYTE DETECTION SYSTEM, MODEL BIOPLEX 2200Bio-Rad Laboratories, Inc.2004-12-20
K042416ATHENA MULTI-LYTE ANA-II TEST SYSTEMZeus Scientific, Inc.2004-10-08
K034013REAADS DSDNA QUANTITATIVE TEST KIT, MODEL 022-001Corgenix, Inc.2004-01-08
K030775AUTO I.D. JO-1, SCL-70 & PCNA POSITIVE CONTROL SERUMImmuno Concepts, N.A. , Ltd.2003-05-12
K024218LIQUICHEK ANTI-SS-A CONTROL, POSITIVE, CATALOG #114Bio-Rad2003-01-17
K024232LIQUICHEK ANTI-SS-B CONTROL, POSITIVE, CATALOG #113Bio-Rad2003-01-17
K024223LIQUICHEK ANTI-RNP CONTROL, POSITIVE, CATALOG #116Bio-Rad2003-01-13
K024226LIQUICHEK ANTI-SCL-70 CONTROL, POSITIVE, CATALOG #116Bio-Rad2003-01-10
K021257ANA LINE BLOT, CATALOG NUMBER: KALABI (20 TESTS)Diagnostic Products Corp.2002-06-03
K021103MODIFICATION TO ZEUS SCIENTIFIC'S ATHENA MULTI-LYTE ANA TEST SYSTEMZeus Scientific, Inc.2002-04-24
K011244ZEUS SCIENTIFIC, INC. ATHENA MULTI-LYTE ANA TEST SYSTEMZeus Scientific, Inc.2001-12-10
K993294DIAMEDIX IS-ANA ELISA SCREEN TEST SYSTEMDiamedix Corp.1999-10-25

Legacy Summary#

summary

FDA Review#

Decision Summary